Last update 20 Mar 2025

Misetionamide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Taurultam analogue
+ [1]
Action
inhibitors
Mechanism
LPS inhibitors(Lipopolysaccharide (LPS) inhibitors), MYC inhibitors(Myc proto-oncogene protein inhibitors), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC3H7NO3S
InChIKeyGHDARLKSYBCZRE-UHFFFAOYSA-N
CAS Registry856785-75-6

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 2--
Pancreatic adenocarcinoma metastaticPhase 1
United States
14 Jan 2019
Pancreatic Cancer, AdultPhase 1
United States
14 Jan 2019
Breast CancerPreclinical
United States
22 Apr 2024
Colorectal CancerPreclinical
United States
21 Nov 2023
MelanomaPreclinical
United States
21 Nov 2023
Squamous Cell CarcinomaPreclinical
United States
21 Nov 2023
Ovarian CancerPreclinical
United States
17 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
49
Misetionamide-gemcitabine
(onxuaonzuh) = ieuehjrhok jiopzkqmlb (qglodhkven )
Positive
09 Oct 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free